Information about Nathypharm
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0837.507.106

VAT liability
Yes
Established
04-07-2011
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Nathypharm

2024 2023 2022 2021
Profit/Loss -47,903 -403 % 15,804 -74 % 61,707 187 % 21,507
Turnover - 172,669 -2 % 176,721 59 % 111,304
Equity 65,374 -42 % 113,277 16 % 97,473 173 % 35,767
Gross margin -4,355 -105 % 80,275 -18 % 98,452 161 % 37,693

Publications from Nathypharm

Date Publication
14-07-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Goal - Resignations, Appointments - General meeting - Financial Year (FR)
06-07-2011 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Nathypharm?
The VAT number of Nathypharm is BE 0837.507.106.
Wat is the PEPPOL ID of Nathypharm?
There is no information available about the PEPPOL ID of Nathypharm or the company is not yet registered on the PEPPOL network.
When was Nathypharm founded?
Nathypharm was founded on 04-07-2011.
What is the address of Nathypharm?
The current registered office of Nathypharm is located at Rue Du Bois De Siroux 36, 5300 Andenne.
When was the last time Nathypharm filed their annual financial statements?
The most recent financial statements of Nathypharm were filed on 07-10-2025.
How many employees does Nathypharm have?
There are currently no employees working at Nathypharm or no workforce information is available.
What is the annual turnover of Nathypharm?
At the time of its most recent financial statements, Nathypharm did not publish any turnover figures. Nathypharm reported a gross margin of -€4,354.98.